PMH2 EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF SCHIZOPHRENIA
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)73315-0
https://www.valueinhealthjournal.com/article/S1098-3015(11)73315-0/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
1474
First Page :
A553
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73315-0&doi=10.1016/S1098-3015(11)73315-0